Kamada Ltd.
KMDA.TA
Get informed when a big investor buys or sells
+ FollowMarket Cap$479.44M
Close$
Share Statistics
| Market cap | $479.44 Million |
|---|---|
| Enterprise Value | $461.77 Million |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | 8.28% |
|---|---|
| Return on Assets | 5.83% |
| Return on Invested Capital | 7.58% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.4 |
| Enterprise Value to EBIT | 18.25 |
| Enterprise Value to Net Income | 20 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$0.33
Average shareholder expectationRevenue Estimate
$151.33 M
Average shareholder expectationNext Earnings Call
Expected Date
November 16, 2026
EPS Estimate
$0.39
Average shareholder expectationRevenue Estimate
$161.53 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Kamada Ltd
316 employees
CEO: Amir London Kamada Ltd. engages in the development and production of pharmaceutical products. It operates through the Proprietary Products segment and the Distribution segment. The Proprietary Products segment covers the development, manufacture, an...